Atıf Formatları
COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. RUHI Et Al. , "COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION," TRANSPLANT INTERNATIONAL , pp.300-301, 2017

RUHI, C. Et Al. 2017. COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION. TRANSPLANT INTERNATIONAL , 300-301.

RUHI, C., TugCu, M., KasapogLu, U., Gokce, A. M., ATA, P., & Titiz, I. M., (2017). COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION. TRANSPLANT INTERNATIONAL , 300-301.

RUHI, Caglar Et Al. "COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION," TRANSPLANT INTERNATIONAL , 300-301, 2017

RUHI, Caglar Et Al. "COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION." TRANSPLANT INTERNATIONAL , pp.300-301, 2017

RUHI, C. Et Al. (2017) . "COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION." TRANSPLANT INTERNATIONAL , pp.300-301.

@article{article, author={Caglar RUHI Et Al. }, title={COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION}, journal={TRANSPLANT INTERNATIONAL}, year=2017, pages={300-301} }